Fractionation schemes in adjuvant radiotherapy for breast cancer: review of the evidence and therapeutic approach at the National Institute of Cancerology, Colombia

被引:0
|
作者
Caicedo-Martinez, Maria [1 ]
del Castillo, Flavio Jose Rosero-Diaz [2 ]
Abi-Saab, Luis Guzman [3 ]
Briceno-Morales, Ximena [3 ]
Gamboa-Garay, oscar Andres [4 ]
Esguerra-Cantillo, Jose Alejandro [4 ]
Alvarez-Martinez, Alex [4 ]
Guerrero-Lizcano, Eduardo [4 ]
Ballesteros-Gomez, Holman [4 ]
Torres-Silva, Luis Angel [4 ]
Lehmann-Mosquera, Carlos [3 ]
Marino-Lozano, Ivan [3 ]
Garcia-Mora, Mauricio [3 ]
Aristizabal, Javier Angel [3 ]
Suarez-Rodriguez, Raul [3 ]
Duarte-Torres, Carlos Alfonso [3 ]
Diaz-Casas, Sandra Esperanza [3 ]
机构
[1] Univ Mil Nueva Granada, Inst Nacl Cancerol, Especializac Oncol Radioterap, Bogota, DC, Colombia
[2] Fdn Univ Ciencias Salud, Especializac Mastol, Inst Nacl Cancerol, Bogota, DC, Colombia
[3] Unidad Func Seno & Tejidos Blandos, Inst Nacl Cancerol, Bogota, DC, Colombia
[4] Inst Nacl Cancerol, Grp Area Oncol Radioterap, Bogota, DC, Colombia
来源
REVISTA COLOMBIANA DE CANCEROLOGIA | 2024年 / 28卷 / 01期
关键词
breast neoplasms; radiotherapy; treatment outcome; dose fractionation; radiation; radiation dose hypofractionation; female; postoperative care; UK STANDARDIZATION; FOLLOW-UP; CONSERVING SURGERY; IRRADIATION; WOMEN; TRIAL; HYPOFRACTIONATION; LUMPECTOMY; MASTECTOMY; OLDER;
D O I
10.35509/01239015.973
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiotherapy is a fundamental component in the management of breast cancer, particularly in the adjuvant setting, as its benefits in the treatment of breast cancer in terms of local recurrence, disease -free survival, and overall survival have been widely demonstrated. Hypofractionated radiation schedules are the current standard of adjuvant treatment in patients with early -stage breast cancer. Thus, the Radiation Oncology Unit and the Functional Unit for Breast and Soft Tissue Tumors of the Instituto Nacional de Cancerologia (INC) (Bogota, Colombia) decided to review the evidence on the subject and establish indications for different hypofractionation schemes at the INC, both for patients with cancers in early stages and for those with locally advanced tumors.
引用
收藏
页数:82
相关论文
共 50 条
  • [21] Review of breast cancer clinical trials conducted by the national surgical adjuvant breast project
    Newman, Lisa A.
    Mamounas, Eleftherios P.
    SURGICAL CLINICS OF NORTH AMERICA, 2007, 87 (02) : 279 - +
  • [22] Systemic treatment for advanced HER2 positive breast cancer. Review of the evidence and therapeutic approach at the Instituto Nacional de Cancerologia - Colombia
    Martinez-Villacres, Juanita
    Luna-Meza, Angela M.
    Ballen, Diego F.
    Suarez-Rodriguez, Raul
    Saenz-Ladino, Anderson
    Oswaldo Sanchez-Castillo, Jesus
    Contreras-Mejia, Fernando
    Lehmann-Mosquera, Carlos
    Angel-Aristizabal, Javier
    Bruges-Maya, Ricardo
    Guzman-AbiSaab, Luis
    Briceno-Morales, Ximena
    Rojas, Eduardo
    Garcia-Mora, Mauricio
    Marino-Lozano, Ivan
    Diaz-Casas, Sandra E.
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2023, 27 : 42 - 51
  • [23] Hypofractionation Radiotherapy vs. Conventional Fractionation for Breast Cancer: A Comparative Review of Toxicity
    Youssef, Ashraf
    Stanford, Jason
    CUREUS, 2018, 10 (10):
  • [24] Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options
    Chirag Shah
    Rahul Tendulkar
    Timothy Smile
    Anish Nanavati
    Bindu Manyam
    Ehsan Balagamwala
    Yvonne Pham
    Radhika Takiar
    Jessica Wobb
    Atif Khan
    Douglas Arthur
    David Wazer
    Frank Vicini
    Annals of Surgical Oncology, 2016, 23 : 3880 - 3890
  • [25] Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options
    Shah, Chirag
    Tendulkar, Rahul
    Smile, Timothy
    Nanavati, Anish
    Manyam, Bindu
    Balagamwala, Ehsan
    Pham, Yvonne
    Takiar, Radhika
    Wobb, Jessica
    Khan, Atif
    Arthur, Douglas
    Wazer, David
    Vicini, Frank
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 3880 - 3890
  • [26] Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update A Review
    Jinih, Marcel
    Relihan, Norma
    Corrigan, Mark A.
    O'Reilly, Seamus
    Redmond, Henry P.
    BREAST JOURNAL, 2017, 23 (06): : 694 - 705
  • [27] COST EFFECTIVENESS OF A STUDY ON THE USE OF TRASTUZUMAB AS ADJUVANT TREATMENT OF EARLY BREAST CANCER HER2 POSITIVE IN THE NATIONAL CANCER INSTITUTE OF COLOMBIA, FROM THE POINT OF VIEW OF THE PAYING
    Diaz, J. A.
    Sanchez, J.
    Echeverry, J.
    VALUE IN HEALTH, 2009, 12 (07) : A496 - A496
  • [28] Fractionation in adjuvant radiotherapy for invasive breast cancer and ductal carcinoma in situ in Ontario, Canada from 2009 to 2015
    Chan, Stephanie
    Sutradhar, Rinku
    Yao, Zhan
    Chow, Edward
    Lee, Justin
    Wan, Bo Angela
    Paszat, Lawrence
    BREAST JOURNAL, 2020, 26 (04): : 602 - 616
  • [29] THE NATIONAL-CANCER-INSTITUTE AUDIT OF THE NATIONAL-SURGICAL-ADJUVANT-BREAST-AND-BOWEL-PROJECT-PROTOCOL-B-06
    CHRISTIAN, MC
    MCCABE, MS
    KORN, EL
    ABRAMS, JS
    KAPLAN, RS
    FRIEDMAN, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22): : 1469 - 1474
  • [30] Radiation Boost After Adjuvant Whole Breast Radiotherapy: Does Evidence Support Practice for Close Margin and Altered Fractionation?
    Gulstene, Stephanie
    Raziee, Hamid
    FRONTIERS IN ONCOLOGY, 2020, 10